ASDAQ:OCGN) is a clinical-stage biopharmaceutical company . link to VCHART indicator will be published in 12 days due to tradingview restrictions
hi all bro... OCUGEN firts target. 5.05 second 5.87 . and 6.10 big target:10.28 *****important- ***** thin line above price is the first target. thin line below price is support.. stop point. Fibonacci correction between the highest price and lowest fiat in the chart area are thick lines.. thick lines are hard support and hard resistances.. main target in...
Today we were trading in what seems to be and ascending triangle. We broke out of the pattern at the end of the day with a nice volume. I can see a continuation into the end of the week and we might be able to see mid 4's or maybe even 5's by friday. A close over 4 would be very bullish.
With the canadian update and according to the price action lately, i can see it climbing back in the 4's and continue the uptrend through the end of the week.
Here is an example of the "Roulette Theory" that I have created by myself. The Roulette Theory is very simple, it is a theory that works on the probability of the candle colours. When a roulette table spins, you have 3 options, Red, Black and Green ( ZERO). The probability of have many REDs is much lower than having more equal amounts of RED and Black. When a...
Yesterday saw the price of Ocugen shoot up on the open as pre-market was showing huge open interest. This gain was quickly swallowed and lost due to a price gap formed pre market. The gap was filled in the last 15 minutes of the trading session so lets see what happens from here.
test Ocugen, Inc. operates as a clinical stage biopharmaceutical company. The Company offers products for improving the body's ability to regenerate healthy cartilage, joint function, and prevention of degenerative diseases. Ocugen serves patients and orthopedist throughout the United States.
Best Vaccine pandemic play!! $Ocugen has just proven to have a vaccine that ( Covaxin) can neutralize both Omnicron ( most infectious ) and the Delta variant( most violent ). $Ocugen has seen a beating! Last Quarter the company dropped nearly 50% from previous highs . I'm expecting a return to those highs some time late spring/early...
wait a minute, havent looked into this for a while. Is this where reversal happens? dont like the stocks but the structure is ok-ish
OCGN (Ocugen) has formed an inverse head and shoulders structure after completing a 7 wave crashing structure. The first 5 waves up was completed, followed by a recently completed ABC corrective pattern that I believe is also complete. The targets are quite spectacular but so is the possible increase in sales this year. The increase in sales could be as much as...
Imagine if Pfizer already had its bull run, and the price of the stock never goes higher than last ATH? Imagine if investors realised there was a massive inverse head and shoulder on $OCGN - The biggest I’ve ever seen, in my entire career
Trying a few 12/31 $6 calls at $0.25, this has potential to pop again. Looking for biotech plays into year end...
New Data suggest COVAXIN (BBV152) may provide protection against current and future variants! data from a Phase 3 trial that included nearly 25,800 participants: 77.8% overall efficacy, 93.4% efficacy against severe illness and 65.2% efficacy against the Delta variant. 52 Week Range 0.28 - 18.77 My price target is the 10.30usd resistance.
OCUGEN do you think it will go up ugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa,...
extremely shallow nature of wave (2), wave (3) at 1.618 extension of wave 1 is ridiculously high.
Price action on OCGN on a weekly time frame using strictly Support and Resistance. looking back at what historical price has done when it has hit this region, it is clear to what should happen in the coming weeks. Nice and easy set up.
I don't know the fundamentals of this company so I am using pure technical analysis on this :) risk to reward looks pretty good